According to the United States Surveillance, Epidemiology and End Results (SEER) program, the survival rate of patients diagnosed with prostate, malignant melanoma, bowel, female breast, non-Hodgkin lymphoma and leukaemia cancers, has improved about 40% over the last 40 years. What are some of the reasons behind this and what is the situation in South Africa...